Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 20 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

Phase 2
5(50.0%)
N/A
4(40.0%)
Phase 3
1(10.0%)
10Total
Phase 2(5)
N/A(4)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT04771871Phase 2Recruiting

MicroRNA Profiles in Triple Negative Breast Cancer

Role: collaborator

NCT07543289Not Yet Recruiting

Hydroxyurea Optimisation in Sickle Cell Disease

Role: collaborator

NCT05766007Recruiting

Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum

Role: collaborator

NCT07303699Phase 2Recruiting

ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

Role: lead

NCT06199921Phase 2Recruiting

ATORvastatin in Pulmonary TUBerculosis

Role: lead

NCT04501419Not ApplicableRecruiting

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria

Role: collaborator

NCT05686499Not ApplicableRecruiting

Building Capacity for Screening & Early Diagnosis of Colorectal Cancer Through a Comprehensive Colonoscopy Training Program in Nigeria

Role: lead

NCT05044689Recruiting

Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria

Role: lead

NCT00582257Completed

Early Onset and Familial Gastric Cancer Registry

Role: collaborator

NCT06532318Phase 3Not Yet Recruiting

Comparative Study Between Platelet Rich Plasma and Steroid Injection in Trigger Finger Treatment

Role: lead

NCT05679960Not ApplicableSuspended

Point of Care, Real-Time Urine Metabolomics Test to Diagnose Colorectal Cancers and Polyps in Low-and Middle-Income Countries

Role: lead

NCT03173729Completed

Point of Care Test to Diagnosed Colorectal Cancer and Polyps in Low Middle Income Countries

Role: lead

NCT04721795Phase 2Completed

Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)

Role: lead

NCT05834933Not ApplicableCompleted

Nigerian Breast Cancer Risk-Reduction Study

Role: collaborator

NCT02269462Completed

A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation

Role: collaborator

NCT03185637Completed

Children's Surgery in Sub-Saharan Africa

Role: collaborator

NCT03032874Completed

Community Based Screening for Colorectal Cancer in an Underserved High Risk Population in Nigeria

Role: lead

NCT02888808Completed

Relationship of Obesity With GERD Among Nigerians

Role: lead

NCT02855385Completed

Barriers to Care in Patients With Rectal Bleeding in Nigeria

Role: lead

NCT01946256Phase 2Completed

Treatment of Antenatal Chlamydia Infection

Role: lead

All 20 trials loaded